Keisuke Yonehara receives grant from the Novo Nordisk Foundation
Group Leader Keisuke Yonehara has been awarded a 2 year project grant of 1.2 mio. DKK from the Novo Nordisk Foundation, Medical and Natural Sciences Research, to support his research on function and dysfunction of optokinetic circuits in mice.